2021 annual financial data
Autolus Therapeutics 2021 Operating cash flow margin
Direct answer
Operating cash flow margin was -7,820.9%.
Operating income was -140.37M USD and net income was -142.1M USD.
Operating cash flow was -117.86M USD.
Get free Autolus Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1.51M USD
- Operating income
- -140.37M USD
- Net income
- -142.1M USD
- Operating cash flow
- -117.86M USD